Compare VTOL & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTOL | TNDM |
|---|---|---|
| Founded | 1948 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2011 | 2013 |
| Metric | VTOL | TNDM |
|---|---|---|
| Price | $41.95 | $15.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 19 |
| Target Price | ★ $58.00 | $28.00 |
| AVG Volume (30 Days) | 165.0K | ★ 2.5M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | ★ 34.58 | N/A |
| EPS | ★ 0.44 | N/A |
| Revenue | ★ $1,490,512,000.00 | $1,014,736,000.00 |
| Revenue This Year | $11.64 | $8.11 |
| Revenue Next Year | $5.59 | $11.85 |
| P/E Ratio | $95.84 | ★ N/A |
| Revenue Growth | 5.30 | ★ 7.93 |
| 52 Week Low | $32.43 | $10.00 |
| 52 Week High | $50.38 | $29.65 |
| Indicator | VTOL | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 44.19 | 41.33 |
| Support Level | $40.69 | $11.86 |
| Resistance Level | $42.44 | $15.75 |
| Average True Range (ATR) | 1.21 | 1.25 |
| MACD | 0.19 | -0.16 |
| Stochastic Oscillator | 36.73 | 3.97 |
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers are in the UK, Norway, the USA, Nigeria, and Others. The offshore energy customers use services to transport personnel to, from and between offshore energy installations. The majority of revenue is generated from Offshore Energy Services.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.